Avadel Pharmaceuticals Plc (AVDL)

21.64 0.00 (0.00%) USD  |  NASDAQ  |  Sep 04, 16:00
More

Avadel Pharmaceuticals SG&A Expense (TTM) : 191.46M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AVDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1996. Start Trial.
Date Value
September 30, 2025 191.46M
June 30, 2025 179.22M
March 31, 2025 178.00M
December 31, 2024 181.04M
September 30, 2024 177.72M
June 30, 2024 176.49M
March 31, 2024 175.86M
December 31, 2023 151.70M
September 30, 2023 127.38M
June 30, 2023 102.32M
March 31, 2023 77.35M
December 31, 2022 74.52M
September 30, 2022 78.56M
June 30, 2022 85.75M
March 31, 2022 79.12M
December 31, 2021 68.50M
September 30, 2021 56.44M
June 30, 2021 43.58M
March 31, 2021 35.50M
December 31, 2020 32.40M
September 30, 2020 31.09M
June 30, 2020 27.99M
March 31, 2020 27.65M
December 31, 2019 30.18M
September 30, 2019 45.72M
Date Value
June 30, 2019 65.23M
March 31, 2019 86.32M
December 31, 2018 100.36M
September 30, 2018 100.22M
June 30, 2018 86.95M
March 31, 2018 71.54M
December 31, 2017 58.86M
September 30, 2017 46.49M
June 30, 2017 47.67M
March 31, 2017 46.53M
December 31, 2016 44.18M
September 30, 2016 40.30M
June 30, 2016 32.13M
March 31, 2016 26.71M
December 31, 2015 21.71M
September 30, 2015 19.00M
June 30, 2015 18.53M
March 31, 2015 16.96M
December 31, 2014 16.01M
September 30, 2014 17.10M
June 30, 2014 15.92M
March 31, 2014 14.33M
December 31, 2013 13.31M
September 30, 2013 11.07M
June 30, 2013 11.25M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Jazz Pharmaceuticals Plc 1.679B
Perrigo Co. Plc 997.20M
GH Research Plc 24.75M
Cosmo NV 34.02M
Alkermes Plc 841.17M